In stroke patients, serum levels of insulin-like growth factor-1 (IGF-1) correlate positively with clinical outcome (Åberg et al., 2011, 2018; De Smedt et al., 2011; Saber et al., 2017) suggesting that IGF-1 may exert neuroprotective effects. The gene discussed is IGF1; the disease is stroke disorder.